These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 34869761)
1. Development of a 15-Gene Signature Model as a Prognostic Tool in Sex Hormone-Dependent Cancers. Xia Z; Xiao J; Liu A; Chen Q Biomed Res Int; 2021; 2021():3676107. PubMed ID: 34869761 [TBL] [Abstract][Full Text] [Related]
2. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma. Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J Front Immunol; 2021; 12():788431. PubMed ID: 34970268 [TBL] [Abstract][Full Text] [Related]
3. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis. Li H; Zhou Q; Wu Z; Lu X Ann Transl Med; 2023 Jan; 11(2):100. PubMed ID: 36819577 [TBL] [Abstract][Full Text] [Related]
6. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis. Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135 [TBL] [Abstract][Full Text] [Related]
7. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
8. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer. Feng S; Ning L; Zhang H; Wang Z; Lu Y PeerJ; 2024; 12():e17861. PubMed ID: 39119106 [TBL] [Abstract][Full Text] [Related]
9. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma. Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496 [TBL] [Abstract][Full Text] [Related]
10. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance. Zheng C; Guo H; Mo Y; Liu G Recent Pat Anticancer Drug Discov; 2024; 19(5):681-694. PubMed ID: 37653627 [TBL] [Abstract][Full Text] [Related]
11. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma. Ouyang D; Li R; Li Y; Zhu X J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849 [TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
13. The prognostic value of arachidonic acid metabolism in breast cancer by integrated bioinformatics. Li W; Guo X; Chen C; Li J Lipids Health Dis; 2022 Oct; 21(1):103. PubMed ID: 36243728 [TBL] [Abstract][Full Text] [Related]
14. Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation. Yuan Y; Chen Z; Cai X; He S; Li D; Zhao W Front Oncol; 2021; 11():766947. PubMed ID: 34868993 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer. Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547 [TBL] [Abstract][Full Text] [Related]
16. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis. You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731 [TBL] [Abstract][Full Text] [Related]
17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
18. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer. Li W; Sang M; Hao X; Jia L; Wang Y; Shan B J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586 [TBL] [Abstract][Full Text] [Related]
19. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma. Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815 [TBL] [Abstract][Full Text] [Related]
20. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer. Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]